top of page
Rinnit logo – modern health products and health news

Gene Therapy: A New Era of Precision Medicine

Oct 8
5 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026

Quick Answer: What is gene therapy?

Gene therapy is a treatment that changes or replaces disease-causing genes to restore normal cell function, using techniques such as gene addition, editing and silencing, often delivered through viral vectors [1]. Focused mainly on single-gene disorders, it offers an alternative to lifelong symptom management, with long-term benefits for conditions such as sickle cell disease and spinal muscular atrophy.

What the research says

  • A one-time gene therapy sharply cut bleeding in hemophilia B. In a phase 3 trial of 54 men, a single infusion of etranacogene dezaparvovec lowered the annualized bleeding rate from 4.19 to 1.51 (rate ratio 0.36, 95% Wald CI 0.20-0.64), and no treatment-related serious adverse events occurred (Pipe et al., N Engl J Med, 2023) [2].

  • Benefit can last for years, with a liver-enzyme rise to watch. A review reported sustained clinical benefit for more than 5 years after a single infusion of an adeno-associated virus vector, and noted that a symptom-free, self-limiting rise in the liver enzyme ALT is commonly seen within the first 12 months (Nathwani, Hematology Am Soc Hematol Educ Program, 2022) [3].

  • Earlier treatment works better, but cost is a major concern. In spinal muscular atrophy, three therapies, including gene replacement with onasemnogene abeparvovec, have been available since 2016. All three work better when given before symptoms appear, and the authors weigh their benefits against high costs to patients and health-care systems (Yeo et al., Lancet Neurol, 2024) [4].

How Gene Therapy Works

At its core, gene therapy is about providing the body with the correct instructions to produce essential proteins. This is achieved through three primary methods: gene addition, which inserts a functional copy of a gene; gene editing, which uses molecular tools to fix a mutation; and gene silencing, which stops a harmful gene from operating [1]. These genetic packages are often delivered using harmless viral vectors that act as microscopic delivery vehicles [1].

Mechanism

Description

Primary Use Case

Gene Addition

Inserts a working copy of a gene [1]

Protein deficiency disorders

Gene Editing

Fixes a mutation using CRISPR/Cas9 [1]

Correcting specific DNA errors

Gene Silencing

"Turns off" a disease-causing gene [1]

Stopping harmful protein production

Stem Cell Preparation

Modifies stem cells in a laboratory [1]

Blood and immune disorders

Delivery Methods and Preparation

The success of gene therapy depends on getting the new genetic material into the right cells. This is typically done in two ways: "in vivo," where a vector is injected or infused directly into the patient, or "ex vivo," where a patient's own stem cells are removed, modified in a lab, and then returned. Preparation for these procedures can be intensive, sometimes requiring genetic testing, blood draws, or even chemotherapy to clear space for the newly modified cells to thrive.

Medical illustration of a viral vector delivering a functional gene into the nucleus of a human cell to replace a malfunctioning gene – rinnit.com

Conditions Treated and FDA Successes

Gene therapy has shown the greatest promise in treating conditions caused by a change in a single gene [1]. The U.S. Food and Drug Administration (FDA) has already approved several landmark treatments for inherited blood disorders, neuromuscular conditions, and retinal diseases [1]. These therapies, while often one-time treatments, require significant expertise and specialized facilities to administer effectively.

Illustration of a specialized laboratory where scientists prepare stem cells for ex vivo gene therapy – rinnit.com

The Benefits and Challenges

The primary benefit of gene therapy is its ability to target the root cause of a disease rather than just managing symptoms [1]. For many, it offers a one-time convenience that eliminates the need for daily medication [1]. However, challenges remain, including the high cost of development, limited availability in some regions, and the risk of immune system reactions to the delivery vectors. Despite these hurdles, the potential for life-changing outcomes continues to drive rapid innovation in the field.

Conceptual illustration of a damaged DNA strand being repaired, representing how gene therapy restores health at the genetic level – rinnit.com

Conclusion

Gene therapy represents one of the most significant advancements in modern medicine, offering a bridge between genetic science and clinical healing. As our understanding of the human genome deepens and delivery technologies become more refined, the list of treatable conditions will only grow. For patients and families affected by genetic disorders, gene therapy is not just a scientific achievement. It is a beacon of hope for a healthier, more vibrant future.

Call to Action: If you or your family is living with a genetic condition, ask your doctor or a genetic counselor whether an approved gene therapy exists for your specific mutation and whether you may be a candidate.

Frequently Asked Questions

Is gene therapy a one-time treatment?

Yes, many currently approved gene therapies are designed to be one-time interventions that provide long-lasting or even permanent benefits.

What is the role of CRISPR in gene therapy?

CRISPR/Cas9 is a precision gene-editing tool that allows scientists to cut and repair specific sections of DNA to fix disease-causing mutations.

Can gene therapy treat all genetic diseases?

Currently, gene therapy is most effective for disorders caused by a mutation in a single gene, though research is expanding into more complex conditions.

Are the viruses used in gene therapy dangerous?

The viral vectors are modified so they cannot cause the infection they came from, but they can still trigger serious immune reactions, including liver injury that has rarely been fatal, so your care team will monitor you closely after treatment.

What is the difference between in vivo and ex vivo therapy?

In vivo therapy delivers the gene directly into the patient's body, while ex vivo therapy involves modifying a patient's cells in a laboratory before returning them.

Does gene therapy have side effects?

Like any medical treatment, side effects are possible, including immune system reactions to the delivery vector or side effects from preparatory treatments like chemotherapy.

How do I know if I am a candidate for gene therapy?

Candidacy typically requires specialized genetic testing to confirm the presence of a specific gene mutation that an approved therapy is designed to treat.

Is gene therapy expensive?

Gene therapies are among the most expensive medical treatments due to the high cost of research, specialized manufacturing, and personalized delivery.

Can gene therapy be used for cancer?

Yes, scientists are actively investigating and developing gene therapies to help the immune system recognize and destroy cancer cells.

How long has gene therapy been studied?

While its clinical use is relatively new, gene therapy has been a subject of intense scientific research and development for several decades.

Content reviewed and produced following the Rinnit editorial framework. Last updated: October 8, 2026.

Related Reading

Biologics: What They Are, Types, Uses and Side Effects explains biologic medicines and how they're used.

References

  1. Cleveland Clinic. Gene Therapy. Cleveland Clinic. June 17, 2025. https://my.clevelandclinic.org/health/treatments/17984-gene-therapy

  2. Pipe SW, Leebeek FWG, Recht M, et al. Gene therapy with etranacogene dezaparvovec for hemophilia B. N Engl J Med. 2023;388(8):706-718. PMID: 36812434. DOI: 10.1056/NEJMoa2211644

  3. Nathwani AC. Gene therapy for hemophilia. Hematology Am Soc Hematol Educ Program. 2022;2022(1):569-578. PMID: 36485127. DOI: 10.1182/hematology.2022000388

  4. Yeo CJJ, Tizzano EF, Darras BT. Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol. 2024;23(2):205-218. PMID: 38267192. DOI: 10.1016/S1474-4422(23)00419-2

Medical disclaimer

This article provides general information and is not a substitute for professional medical advice. Always consult a qualified healthcare provider before making any decision about genetic testing or treatment.

Comments


bottom of page